New pharmacological options in the treatment of Alzheimer's
disease

J 2022

New pharmacological options in the treatment of Alzheimer's disease

KLEINOVA, Lenka; Jaroslav CERMAN; Jakub HLÁVKA a Jakub HORT

Základní údaje

Originální název

New pharmacological options in the treatment of Alzheimer's disease

Autoři

KLEINOVA, Lenka; Jaroslav CERMAN; Jakub HLÁVKA a Jakub HORT

Vydání

Ceska a slovenska neurologie a neurochirurgie, PRAGUE, CZECH MEDICAL SOC, 2022, 1210-7859

Další údaje

Typ výsledku

Článek v odborném periodiku

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 0.500

Označené pro přenos do RIV

Klíčová slova anglicky

Alzheimer?s disease; phase three testing ; of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 14. 4. 2026 16:29, Mgr. Petra Trembecká, Ph.D.

Anotace

V originále

A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.

Citovat

KLEINOVA, Lenka; Jaroslav CERMAN; Jakub HLÁVKA a Jakub HORT. New pharmacological options in the treatment of Alzheimer's disease. Ceska a slovenska neurologie a neurochirurgie. PRAGUE: CZECH MEDICAL SOC, 2022, roč. 85, č. 6, s. 462-469. ISSN 1210-7859. Dostupné z: https://doi.org/10.48095/cccsnn2022462.

@article{2472548,
   author = {Kleinova, Lenka and Cerman, Jaroslav and Hlávka, Jakub and Hort, Jakub},
   article_location = {PRAGUE},
   article_number = {6},
   doi = {https://doi.org/10.48095/cccsnn2022462},
   keywords = {Alzheimer?s disease; phase three testing ; of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection},
   issn = {1210-7859},
   journal = {Ceska a slovenska neurologie a neurochirurgie},
   title = {New pharmacological options in the treatment of Alzheimer's disease},
   url = {https://www.csnn.eu/en/journals/czech-and-slovak-neurology-and-neurosurgery/2022-6-10/new-pharmacological-options-in-the-treatment-of-alzheimer-s-disease-133181},
   volume = {85},
   year = {2022}
}

TY  - JOUR
ID  - 2472548
AU  - Kleinova, Lenka - Cerman, Jaroslav - Hlávka, Jakub - Hort, Jakub
PY  - 2022
TI  - New pharmacological options in the treatment of Alzheimer's disease
JF  - Ceska a slovenska neurologie a neurochirurgie
VL  - 85
IS  - 6
SP  - 462-469
EP  - 462-469
PB  - CZECH MEDICAL SOC
SN  - 12107859
KW  - Alzheimer?s disease
KW  - phase three testing
KW  - of new drugs
KW  - β -amyloid
KW  - tau protein
KW  - neuroinflammatory theory
KW  - ric symptoms
KW  - neuroprotection
UR  - https://www.csnn.eu/en/journals/czech-and-slovak-neurology-and-neurosurgery/2022-6-10/new-pharmacological-options-in-the-treatment-of-alzheimer-s-disease-133181
N2  - A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
ER  -

KLEINOVA, Lenka; Jaroslav CERMAN; Jakub HLÁVKA a Jakub HORT. New pharmacological options in the treatment of Alzheimer's disease. \textit{Ceska a slovenska neurologie a neurochirurgie}. PRAGUE: CZECH MEDICAL SOC, 2022, roč.~85, č.~6, s.~462-469. ISSN~1210-7859. Dostupné z: https://doi.org/10.48095/cccsnn2022462.

Přehled o publikaci